Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 5/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17487972 | 0.89 | CTSK (0.35) | CTSKNAAAFFAR4GRM2 | |
| SCHEMBL17490454 | 0.88 | CTSK (0.39) | CTSKNAAAFFAR4HCRTR1HCRTR2 | |
| SCHEMBL17487978 | 0.87 | FFAR4 (0.33) | FFAR4 | |
| SCHEMBL17487816 | 0.84 | HCRTR1 (0.35) | CTSKNAAAFFAR4HCRTR1HCRTR2 | |
| SCHEMBL17487985 | 0.84 | RARB (0.34) | FFAR4 | |
| SCHEMBL12739990 | 0.82 | LYPLA1 (0.36) | NAAAFFAR4 | |
| SCHEMBL17487980 | 0.82 | RARB (0.39) | FFAR4 | |
| SCHEMBL8747919 | 0.82 | SPHK1 (0.34) | CTSKNAAAHCRTR1HCRTR2 | |
| SCHEMBL17487973 | 0.81 | RARB (0.32) | FFAR4 | |
| SCHEMBL12740001 | 0.81 | FFAR4 (0.36) | NAAAFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9441161-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-09-13 | — | — | US | disclosed |
| US-20160032187-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160032187-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | OCIAD1, OCIAD2, PIEZO1 | CTSK 2692/4885NAAA 4794/4885FFAR4 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.